VIEW PDF INVITATION TO ATTEND
VIEW REGISTRATION WEBSITE
On behalf of the Organizing Committee, it is our privilege to invite you to attend ICTR-PHE 2016 (International Conference on Translational Research in Radio-Oncology and Physics for Health), which will take place in Geneva on February 15 – 19, 2016.
ICTR-PHE 2014 brought up an overwhelming number of proposals in both the diagnostic and therapeutic fields. They ranged from new detectors and next-generation imaging techniques, to accelerator-based facilities for making new isotopes such as radiotracers and drugs. For instance, presentations covered various activities related to the technologies developed at CERN, including the design of specialized accelerators for cancer therapy, the adaptation of the Low Energy Ion Ring (LEIR) to serve as a biomedical facility, radio-isotope production using ISOLDE, medical imaging and applications to improve dosimetry for patients and, finally, large scale computing applications. In biology, it was shown that a better understanding of biomolecular pathways and interactions between tumors and their micro-environment was key to success in team efforts to increase malignant cell killing. Another example of inter-disciplinary scientific program was brought in the framework of the EORTC Symposium: the Synergy of Targeted Agents and Radiotherapy (STAR), was shown to be a unique quality controlled platform for integrated development of anticancer agents with radiotherapy, through a network of radiotherapy centers in Europe.
ICTR-PHE 2016 will be a unique opportunity to gather all scientific communities involved in research programs articulated around the optimization of cancer treatment. Radiochemists, nuclear-medicine physicians, biologists, software developers, accelerator experts, oncologists, and detector and medical radio-physicists will indeed be asked to “think outside the box” and make innovative proposals to boost further the comprehensive approach of cancer management. The red threads of ICTR-PHE 2016 will range from the production of more effective isotopes for clinical use to personalized medicine in imagery, drug selection and treatment planning; from drug-radiation interactions to immunotherapies; and from advances in detection techniques to hadrontherapy. The importance of recent discoveries from researches fostered in the field of molecular radiobiology will also be emphasized in interactive sessions on cancer stem cells, regulation of tumor response to anticancer therapies, normal tissue protection, and viral interactions with cancer development and treatment outcome.
ICTR-PHE 2016 will undoubtedly contribute to strengthen the global platform that the previous conferences have successfully set up and on which chemists, physicists, radiobiologists, and physicians are developing a win-win collaboration at the international level.
The Organizing Committee of ICTR-PHE 2016 is looking forward to welcoming you to Geneva so mark February 15 – 19, 2016 in your agenda now!